In June 2010, South Africa hosted the FIFA World Cup for the first time. Thirty-two teams. More than three million stadium tickets. Fans from every corner of the planet are descending on Johannesburg, Cape Town, Durban, and nine other cities for a month of soccer. It was a historic moment for African sports.
It was also a public health puzzle.
When you pack hundreds of thousands of travelers together from 32 different countries, each person carries not just a passport and a jersey, but also whatever diseases and immunity gaps exist in their home country. Public health officials knew this going into June 2010, and the vaccines they recommended for the tournament tell a story worth knowing.
A Tournament in Winter, and in the Middle of a Measles Outbreak
The World Cup ran from June 11 to July 11, 2010. That timing was important because June and July are winter months in South Africa, as it is located in the Southern Hemisphere. That meant the tournament coincided with peak influenza season, including the , which was still circulating after its emergence in 2009. The southern hemisphere influenza vaccine, available from March 2010, included the H1N1 strain, and health officials urged travelers to get vaccinated before departure.
But influenza wasn't even the biggest concern. . The outbreak had started in South Africa and Namibia in mid-2009, then spread to five neighboring countries by early 2010, driven largely by a decline in first-dose measles vaccine coverage in the region, which dropped from 80% to 65% during 1996–2004 before beginning to recover. . Health officials told travelers who lacked proof of measles vaccination or prior measles infection to get vaccinated before traveling. .
Meningococcal Disease: The Vaccine Recommendation Nobody Saw Coming
Of all the vaccines discussed ahead of the 2010 World Cup, the one that drew the most attention from travel medicine specialists was one many fans had probably never considered: the meningococcal vaccine.
is caused by the bacterium , and it can go from “sore throat” to “life-threatening emergency” in a matter of hours. It spreads through respiratory droplets and close contact, which is exactly the kind of transmission that happens when tens of thousands of people crowd into stadiums, shared transport, hotel rooms, boarding houses, and fan zones.
, but the numbers tick upward from May through October, which maps almost exactly onto the World Cup calendar. The dominant serogroup (strain) in South Africa at the time was one not covered by older meningococcal vaccines. A : the should be given to everyone attending or playing in the tournament and to travelers attending similar large international events in the future. This was the newer conjugate vaccine, not the older polysaccharide version. According to research, conjugate vaccines produce a stronger, longer-lasting immune response and, crucially for crowded settings, also reduce nasal and throat carriage of the bacteria, making vaccinated people less likely to spread it to others.
The fact that this recommendation came from peer-reviewed research rather than just government travel advisories says something interesting about how vaccine guidance actually gets made. Travel medicine specialists were essentially running a real-time risk assessment — calculating who would be exposed, to what, under what crowding conditions — and then matching that against which vaccines could realistically be administered before departure.
Yellow Fever: A Disease That Wasn’t Even There
Here’s a counterintuitive fact: . The mosquito that carries it, Aedes aegypti, lives in tropical climates, and South Africa’s climate doesn’t support stable yellow fever transmission. So why did yellow fever vaccination come up at all?
Because of where some fans were traveling from.
Under the International Health Regulations — the global framework that governs disease control at borders — . The list of affected countries includes most of sub-Saharan Africa and large parts of South America. Fans flying from Brazil, Colombia, Ghana, Senegal, or Côte d’Ivoire needed to present a valid yellow fever vaccination certificate at the border or risk being denied entry. The certificate had to be issued at least 10 days before arrival, because the vaccine takes that long to provide full protection.
For fans traveling through Africa en route to South Africa, there was an additional wrinkle. Health officials in the UK warned that fans routing through Kenya — a common transit hub — . Two countries. Two border crossings. One virus that wasn’t even present at the destination. This is the logistical reality of travel medicine at a global sporting event: the vaccine requirements are shaped not just by the host country’s disease profile, but by every border a fan crosses on the way there.
What About HIV and TB?
South Africa in 2010 had some of the highest HIV and tuberculosis rates in the world. The National Institute for Communicable Diseases guide for World Cup visitors addressed these directly, though neither HIV nor TB has a vaccine in routine use. For HIV, the advice was straightforward: . For TB, . Tuberculosis spreads most efficiently in crowded, enclosed, poorly ventilated spaces, which a large outdoor or well-ventilated stadium is not.
These weren’t vaccine stories. But they were public health stories, and they sat alongside the vaccine recommendations in a way that reminded travelers: the goal isn’t just to update your shot record. It’s to understand the full infectious disease landscape of where you’re going and act accordingly. Vaccines cover some of that landscape. Personal behavior covers the rest.
The Broader Legacy: What the 2010 World Cup Revealed About Global Immunization Gaps
The 2010 World Cup was the first ever held on the African continent. It drew attention to South Africa’s public health strengths: a functioning national disease surveillance system, strong stadium infrastructure, and a National Institute for Communicable Diseases that produced clear guidance in multiple languages. But it also drew attention to something harder to fix: the immunization gaps that exist when a global population mingles.
Measles cases continued to climb in South Africa and neighboring countries through the tournament. A subsequent analysis published in the medical literature noted that the peak of South Africa's measles outbreak coincided directly with the World Cup period. There is no documented mass transmission event linked to the tournament, in part because many international fans arrived with higher vaccination rates than local populations. But the overlap was real, and it’s the kind of thing that keeps epidemiologists up at night: a major outbreak already in progress, an influx of millions of people from around the world, and a vaccine coverage rate that hadn’t yet recovered from years of decline.
The story of vaccines at the 2010 World Cup is also a story about access and equity, themes seen throughout the entire history of vaccination. Fans from wealthy countries could walk into a travel clinic weeks before departure, get their meningococcal conjugate vaccine, their measles booster, and their yellow fever shot, and board a plane with confidence. Fans from countries with weaker health systems had fewer options. The vaccine that protected against the same meningococcal bacteria circulating in South African stadiums was, at the time, not widely available in much of the continent. Public health researchers used the 2010 World Cup spotlight to ask directly: if vaccines had virtually eliminated measles and meningococcal disease in rich countries, what would it take to achieve the same in Africa?
That question didn’t get answered in 2010. It’s still being asked in 2026.